Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alpha Cognition Inc
(OP:
ACOGF
)
0.4100
+0.0200 (+5.13%)
Streaming Delayed Price
Updated: 2:57 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Alpha Cognition Inc
< Previous
1
2
Next >
Alpha Cognition Announces Positive Neuroprotection Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury
February 22, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Announces Participation in January Investor Conferences
January 03, 2022
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Announces Director Change and Stock Option Grant
December 27, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Announce Data from Pre-Clinical Study of ALPHA-1062 for Traumatic Brain Injury
December 06, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Appoints Cedric O’Gorman, M.D., MBA as Chief Medical Officer
December 02, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Reports Third Quarter of Fiscal 2021 Results
November 30, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021
December 06, 2021
LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will...
From
Stock News Now
Via
AccessWire
Alpha Cognition Inc. (TSX.V: ACOG) (OTCQB: ACOGF) Featured in Coverage of Investor Summit Group’s Q4 Virtual Event
November 10, 2021
Via
Investor Brand Network
Alpha Cognition to Present at LD Micro Main Event
October 08, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Provides CEO Update
October 07, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Announces Formation and Members of Scientific Advisory Board and Investor Relations Agreements
October 01, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition, Focused on Neurodegenerative Diseases, CEO Clip Video
September 11, 2021
Vancouver, British Columbia--(Newsfile Corp. - September 11, 2021) - Alpha Cognition (TSXV: ACOG) (OTCQB: ACOGF) - CEO, Michael McFadden speaks...
Via
Newsfile
Alpha Cognition Announces the Acceptance of its US FDA Investigational New Drug Application (IND) for Lead Candidate, ALPHA-1062 for Mild to Moderate Alzheimer’s Disease
September 07, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Reports Second Quarter of Fiscal 2021 Results
September 03, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition to Participate at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021
September 01, 2021
From
Alpha Cognition Inc.
Via
Business Wire
Alpha Cognition Receives Approval to Commence Trading on the OTCQB
August 20, 2021
From
Alpha Cognition Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.